126 related articles for article (PubMed ID: 3902674)
1. The use of oxygen and prostacyclin as pulmonary vasodilators in congenital heart disease.
Bush A; Busst CM; Shinebourne EA
Int J Cardiol; 1985 Nov; 9(3):267-74. PubMed ID: 3902674
[TBL] [Abstract][Full Text] [Related]
2. Does prostacyclin enhance the selective pulmonary vasodilator effect of oxygen in children with congenital heart disease?
Bush A; Busst C; Booth K; Knight WB; Shinebourne EA
Circulation; 1986 Jul; 74(1):135-44. PubMed ID: 3518981
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide, oxygen, and prostacyclin in children with pulmonary hypertension.
Turanlahti MI; Laitinen PO; Sarna SJ; Pesonen E
Heart; 1998 Feb; 79(2):169-74. PubMed ID: 9538311
[TBL] [Abstract][Full Text] [Related]
4. Modification of pulmonary hypertension secondary to congenital heart disease by prostacyclin therapy.
Bush A; Busst C; Knight WB; Shinebourne EA
Am Rev Respir Dis; 1987 Sep; 136(3):767-9. PubMed ID: 3307574
[TBL] [Abstract][Full Text] [Related]
5. Acute effect of oral prostacyclin and inhaled nitric oxide on pulmonary hypertension in children.
Ichida F; Uese K; Hashimoto I; Hamamichi Y; Tsubata S; Fukahara K; Murakami A; Miyawaki T
J Cardiol; 1997 Apr; 29(4):217-24. PubMed ID: 9127838
[TBL] [Abstract][Full Text] [Related]
6. Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance.
Haraldsson A; Kieler-Jensen N; Nathorst-Westfelt U; Bergh CH; Ricksten SE
Chest; 1998 Sep; 114(3):780-6. PubMed ID: 9743166
[TBL] [Abstract][Full Text] [Related]
7. Aerosolized iloprost for pulmonary vasoreactivity testing in children with long-standing pulmonary hypertension related to congenital heart disease.
Limsuwan A; Khosithseth A; Wanichkul S; Khowsathit P
Catheter Cardiovasc Interv; 2009 Jan; 73(1):98-104. PubMed ID: 19089967
[TBL] [Abstract][Full Text] [Related]
8. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
Kieler-Jensen N; Lundin S; Ricksten SE
J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
[TBL] [Abstract][Full Text] [Related]
9. Effect of beraprost sodium on pulmonary vascular resistance in candidates for a Fontan procedure: a preliminary study.
Takahashi K; Mori Y; Yamamura H; Nakanishi T; Nakazawa M
Pediatr Int; 2003 Dec; 45(6):671-5. PubMed ID: 14651539
[TBL] [Abstract][Full Text] [Related]
10. [The pulmonary vasodilatory effect of inhaled prostacyclin and milrinone in heart].
Ricksten S
Rev Esp Anestesiol Reanim; 2001 Dec; 48(10):460-1. PubMed ID: 11792300
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the vasodilator response in primary pulmonary hypertension. Comparing prostacyclin and iloprost administered by either infusion or inhalation.
Opitz CF; Wensel R; Bettmann M; Schaffarczyk R; Linscheid M; Hetzer R; Ewert R
Eur Heart J; 2003 Feb; 24(4):356-65. PubMed ID: 12581683
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary vasodilation with prostacyclin in primary and secondary pulmonary hypertension.
Jones K; Higenbottam T; Wallwork J
Chest; 1989 Oct; 96(4):784-9. PubMed ID: 2507232
[TBL] [Abstract][Full Text] [Related]
13. Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease: vasodilator capacity and cellular mechanisms.
Rimensberger PC; Spahr-Schopfer I; Berner M; Jaeggi E; Kalangos A; Friedli B; Beghetti M
Circulation; 2001 Jan; 103(4):544-8. PubMed ID: 11157720
[TBL] [Abstract][Full Text] [Related]
14. The additive pulmonary vasodilatory effects of inhaled prostacyclin and inhaled milrinone in postcardiac surgical patients with pulmonary hypertension.
Haraldsson s A; Kieler-Jensen N; Ricksten SE
Anesth Analg; 2001 Dec; 93(6):1439-45, table of contents. PubMed ID: 11726420
[TBL] [Abstract][Full Text] [Related]
15. Inhaled nitric oxide in congenital heart disease.
Roberts JD; Lang P; Bigatello LM; Vlahakes GJ; Zapol WM
Circulation; 1993 Feb; 87(2):447-53. PubMed ID: 8425292
[TBL] [Abstract][Full Text] [Related]
16. Inhaled prostacyclin following surgical repair of congenital heart disease--a pilot study.
Carroll CL; Backer CL; Mavroudis C; Cook K; Goodman DM
J Card Surg; 2005; 20(5):436-9. PubMed ID: 16153274
[TBL] [Abstract][Full Text] [Related]
17. A comparison of inhaled nitric oxide with intravenous vasodilators in the assessment of pulmonary haemodynamics prior to cardiac transplantation.
Pagano D; Townend JN; Horton R; Smith C; Clutton-Brock T; Bonser RS
Eur J Cardiothorac Surg; 1996; 10(12):1120-6. PubMed ID: 10369648
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologically induced pulmonary vasodilatation in children and young adults with primary pulmonary hypertension.
Barst RJ
Chest; 1986 Apr; 89(4):497-503. PubMed ID: 2869919
[TBL] [Abstract][Full Text] [Related]
19. Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension.
Rubin LJ; Groves BM; Reeves JT; Frosolono M; Handel F; Cato AE
Circulation; 1982 Aug; 66(2):334-8. PubMed ID: 7046988
[TBL] [Abstract][Full Text] [Related]
20. The acute effects of prostacyclin on pulmonary hemodynamics in patients with pulmonary hypertension secondary to systemic sclerosis.
Menon N; McAlpine L; Peacock AJ; Madhok R
Arthritis Rheum; 1998 Mar; 41(3):466-9. PubMed ID: 9506575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
